Myopericarditis Associated With Smallpox Vaccination Among US Army Personnel – Fort Hood, Texas, 2018

Abstract Objective: In March 2018, the US Department of Defense (DOD) added the smallpox vaccination, using ACAM2000, to its routine immunizations, increasing the number of persons receiving the vaccine. The following month, Fort Hood reported a cluster of 5 myopericarditis cases. The Centers for Disease Control and Prevention and the DOD launched an investigation. Methods: The investigation consisted of a review of medical records, establishment of case definitions, causality assessment, patient interviews, and active surveillance. A 2-sided exact rate ratio test was used to compare myopericarditis incidence rates. Results: This investigation identified 4 cases of probable myopericarditis and 1 case of suspected myopericarditis. No alternative etiology was identified as a cause. No additional cases were identified. There was no statistically significant difference in incidence rates between the observed cluster (5.23 per 1000 vaccinated individuals, 95% CI: 1.7–12.2) and the ACAM2000 clinical trial outcomes for symptomatic persons, which was 2.29 per 1000 vaccinated individuals (95% CI: 0.3–8.3). Conclusions: Vaccination with ACAM2000 is the presumptive cause of this cluster. Caution should be exercised before considering vaccination campaigns for smallpox given the clinical morbidity and costs incurred by a case of myopericarditis. Risk of myopericarditis should be carefully weighed with risk of exposure to smallpox.

[1]  S. Sarkisian,et al.  A Case Series of Smallpox Vaccination-Associated Myopericarditis: Effects on Safety and Readiness of the Active Duty Soldier. , 2018, Military medicine.

[2]  P. Chaplin,et al.  A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis , 2015, PloS one.

[3]  S. de la Motte,et al.  Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population , 2015, PloS one.

[4]  Robert L. Davis,et al.  A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination , 2015, PloS one.

[5]  H. T. Kim,et al.  Clinical features and short-term outcomes of pediatric acute fulminant myocarditis in a single center , 2014, Korean journal of pediatrics.

[6]  D. Fisher,et al.  Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. , 2013, The Journal of infectious diseases.

[7]  D. Haas,et al.  Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. , 2013, The Journal of infectious diseases.

[8]  Cornelia L Dekker,et al.  Algorithm to assess causality after individual adverse events following immunizations. , 2012, Vaccine.

[9]  Robert E Eckart,et al.  Chest pain, ST elevation, and positive cardiac enzymes in an austere environment: differentiating smallpox vaccination-mediated myocarditis and acute coronary syndrome in Operation Iraqi Freedom. , 2012, The Journal of emergency medicine.

[10]  E. Zumbrun,et al.  ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile , 2010, Drug design, development and therapy.

[11]  Akbar H. Khan,et al.  Cardiac Complications after Smallpox Vaccination , 2009, Southern medical journal.

[12]  M. Nieminen,et al.  Etiology of mild acute infectious myocarditis. Relation to clinical features. , 2009, Acta medica Scandinavica.

[13]  M. Imazio,et al.  Myopericarditis: Etiology, management, and prognosis. , 2008, International journal of cardiology.

[14]  T. Maurer,et al.  Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Swerdlow,et al.  Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  W. Lai,et al.  Acute Myopericarditis After Multiple Vaccinations in an Adolescent: Case Report and Review of the Literature , 2007, Pediatrics.

[17]  Niels H. Wulff,et al.  Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. , 2006, Vaccine.

[18]  D. Swerdlow,et al.  Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[19]  D. Swerdlow,et al.  Adverse events associated with smallpox vaccination in the United States, January-October 2003. , 2005, JAMA.

[20]  D. Passaro,et al.  Myocarditis Outbreak among Adults, Illinois, 2003 , 2005, Emerging infectious diseases.

[21]  G. Poland,et al.  The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. , 2005, Vaccine.

[22]  J. Atwood,et al.  Myopericarditis following smallpox vaccination. , 2004, American journal of epidemiology.

[23]  D. Swerdlow,et al.  Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. , 2004, Journal of the American College of Cardiology.

[24]  J. Atwood,et al.  Smallpox vaccination and myopericarditis: a clinical review. , 2004, Journal of the American College of Cardiology.

[25]  S. Ostroff,et al.  Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. , 2003, JAMA.

[26]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[27]  B. Chaitman,et al.  Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination. , 2009, The American journal of medicine.